Validation of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the GHSG HD21 trial.
- DOI
- 10.1002/hem3.70471
- Published
- 2026 Sep
- Container
- HemaSphere
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70471,
title = {Validation of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the GHSG HD21 trial.},
author = {Tharmaseelan H and Jablonski J and Parsons SK and Rodday AM and Evens AM and Zijlstra JM and Fosså A and Molin D and Hertzberg M and Hitz F and Fehr M and Greil R and Melchardt T and Fuchs M and Kaul H and Borchmann P and Ferdinandus J},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70471},
url = {https://doi.org/10.1002/hem3.70471}
}RIS
TY - JOUR TI - Validation of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the GHSG HD21 trial. AU - Tharmaseelan H AU - Jablonski J AU - Parsons SK AU - Rodday AM AU - Evens AM AU - Zijlstra JM AU - Fosså A AU - Molin D AU - Hertzberg M AU - Hitz F AU - Fehr M AU - Greil R AU - Melchardt T AU - Fuchs M AU - Kaul H AU - Borchmann P AU - Ferdinandus J PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70471 UR - https://doi.org/10.1002/hem3.70471 ER -
APA
H, T., J, J., SK, P., AM, R., AM, E., JM, Z., A, F., D, M., M, H., F, H., M, F., R, G., T, M., M, F., H, K., P, B., & J, F. (2026). Validation of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the GHSG HD21 trial.. HemaSphere. https://doi.org/10.1002/hem3.70471
Source records
- pubmed · retrieved 2026-09-25T12:07:06.847Z
- europe-pmc · retrieved 2026-09-25T12:07:06.851Z